Gastroenterology
Conference Coverage
FIRE-3: Cetuximab/FOLFIRI prolongs metastatic colorectal cancer survival
Major finding: Median overall survival with cetuximab plus FOLFIRI was 28.7 months vs.
News
Onsite cytopathology improves pancreatic biopsy quality
Major finding: Onsite cytopathologists identified significantly more samples as suspicious or malignant than did pathologists who examined samples...
Original Report
Impact of pretreatment PET on disease control and treatment decisions in locoregionally advanced esophageal cancer patients treated with chemoradiotherapy
Original Report
Utilization of radiotherapy services by a palliative care unit: pattern and implication
News
Primary tumor resection is linked to growth of CRC liver metastases
Major finding: Patients had ninefold higher odds of radiologic progression of their liver metastases at 3 months if they had a primary tumor...
News
Tumor biology appears to play role in missed interval colorectal cancers
Major finding: At 6-36 months after colonoscopy the rate of missed interval cancers was 3.5%; at 6-60 months the rate was 6%.Data source: A...
News
Completion study key after incomplete colonoscopy
Major finding: Overall, 12% of the patients were found to have clinically significant lesions when they underwent completion studies. Data source...
News
Simultaneous resection reduced repeat intervention
Major finding: No patients who had surgical cytoreduction of liver metastases at the time or primary tumor resection required a repeat hepatic...
News
Robotic pancreatic resection safe in 250-patient series
Major finding: Overall 30- and 90-day mortality rates were 0.8% and 2.0%, respectively, following various types of robotic-assisted major...
News
Cardiorespiratory fitness predicts cancer risk, outcomes in men
Major finding: Compared with men in the lowest cardiorespiratory fitness quintile, hazard ratios for incident lung and colorectal cancer among men...
News
Esophagectomy cases rising steadily
Major finding: In-hospital mortality occurred nationally in 5.8% of esophageal cancer patients who underwent transthoracic esophagectomy compared...